A comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatography

Keywords

AspirinChemistryChromatographyBioavailabilityCalibration curveDetection limitCmaxSolid phase extractionPharmacologyBiochemistryMedicine

Affiliated Institutions

Dublin City University IE

Related Publications

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

Lennart Hansson , Alberto Zanchetti , S. George Carruthers +7 more

1998 The Lancet 5759 citations

Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs

John R. Vane

1971 Nature New Biology 8571 citations

Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets

J. Bryan Smith , A.L. Willis

1971 Nature New Biology 1523 citations

Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen

S. H. Ferreira , Salvador Moncada , John R. Vane

1971 Nature New Biology 934 citations

Antagonism by Aspirin and Fenamates of Bronchoconstriction and Nociception induced by Adenosine-5′-triphosphate

H. O. J. COLLIER , Genevieve James , C Schneider

1966 Nature 95 citations

Publication Info

Year: 1999
Type: article
Volume: 21
Issue: 2
Pages: 383-392
Citations: 57
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

A comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatography

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Kamal A. Sagar, 
                                
                                    Malcolm R. Smyth
                                
                            (1999). 
                            A comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatography. 
                            Journal of Pharmaceutical and Biomedical Analysis
                            , 21
                            (2)
                            , 383-392.
                            https://doi.org/10.1016/s0731-7085(99)00177-6

Identifiers

DOI: 10.1016/s0731-7085(99)00177-6